Featured,Spotlight Stock,Trends & Articles Lobe Acquires Consumer Goods Product Line Vitamind By Dennis Mutua May 05, 2021 Life sciences company focused on psychedelics therapies Lobe Sciences Ltd (CNSX: LOBE) (OTC: GTSIF) announced having purchased Vitamind, a consumer goods product line. Lobe made this acquisition through its wholly owned subsidiary...
Featured,Spotlight Stock,Trends & Articles Champignon Brands Changes its Name to Braxia Scientific Corp By Dennis Mutua May 04, 2021 Medical solutions company specializing on using novel and natural products with an emphasis on psychedelics to treat mental illnesses Champignon Brands Inc. (CSE: SHRF) (OTCQB: SHRMF) announced changing its name to Braxia Scientif...
Featured,Spotlight Stock,Trends & Articles Maine Seeking to Legalize Psychedelics for Adults Over 21 By Dennis Mutua May 03, 2021 A proposal seeking to allow adults over 21 years old in Maine State to legally buy and use psychedelics under the supervisor of a certified psilocybin health officer has been filed. The bill also seeks to legalize psilocybin mushr...
Featured,Shroom News,Spotlight Stock Lobe Life Sciences Files for Key PCT Application By Dennis Mutua April 30, 2021 Life sciences company specializing on psychedelics therapies for mental illness patients Lobe Life Sciences Ltd. (CSE: LOBE) (OTC: GTSIF) announced having submitted application for key Patent Cooperation Treaty (PCT) titled ‘Met...
Featured,Spotlight Stock,Trends & Articles PharmaDrug Granted FDA Orphan Drug Designation of DMT for Prevention of Ischemia-Reperfusion Injury During Organ Transplant By Dennis Mutua April 29, 2021 Biotechnology company focused on development and commercialization of natural medicine and controlled substances including cannabis and psychedelics PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) announced having been granted U.S. Food ...
Featured,Spotlight Stock,Trends & Articles PharmaTher Files For a Provisional Patent for Using Ketamine to Treat Diabetes and Obesity By Dennis Mutua April 28, 2021 Psychedelics Pharmaceutical company specializing in research, development and distribution of psychedelics PharmaTher Ther. (CSE: PHRM) (OTCQB: PHRRF) has filed for a provisional patent with the United States Patent and Trademark ...
Featured,Spotlight Stock,Trends & Articles MindMed Goes Public Becoming Second U.S Public Psychedelics Company By Dennis Mutua April 27, 2021 Biotechnology company engaging in developing and deploying psychedelics infused drugs to treat mental conditions Mind Medicine (MindMed) Inc. is set to start trading on NASDAQ on April 27 making it the second United States psyched...
Featured,Shroom News Cambridge Health Alliance and Harvard Medical School Offering Training on Psychedelics By Dennis Mutua April 26, 2021 Innovative healthcare system Cambridge Health Alliance (CHA) and Harvard Medical School will be offering a continuing education course on psychedelics titled “Meditation and Psychotherapy: Learning from Non-Ordinary States”. ...